Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	82.7	37.79	38.52	54.84
Short-Term Investments	186.97	109.75	-	27.77
Cash & Short-Term Investments	269.67	147.54	38.52	82.61
Cash Growth	226.43%	283.01%	-53.37%	-
Prepaid Expenses	4.01	3.46	0.69	1.22
Total Current Assets	273.68	150.99	39.21	83.83
Property, Plant & Equipment	10.01	10.3	11.62	1.79
Long-Term Investments	85.02	20.51	-	-
Other Long-Term Assets	0.96	3.96	1.12	1.74
Total Assets	369.67	185.75	51.95	87.37
Accounts Payable	5.02	1.19	0.72	0.56
Accrued Expenses	3.35	7.67	6.59	7.7
Current Portion of Leases	1.12	1.07	0.73	-
Other Current Liabilities	0.04	0.49	-	-
Total Current Liabilities	9.53	10.42	8.04	8.25
Long-Term Leases	8.38	8.68	9.75	-
Total Liabilities	17.91	19.1	17.79	8.25
Common Stock	0.04	0.01	0	0
Additional Paid-In Capital	548.99	17	4.52	2.23
Retained Earnings	-197.57	-181.09	-119.4	-72.14
Comprehensive Income & Other	0.3	0.37	-	-0.02
Total Common Equity	351.77	-163.71	-114.88	-69.92
Shareholders' Equity	351.77	166.66	34.16	79.12
Total Liabilities & Equity	369.67	185.75	51.95	87.37
Total Debt	9.5	9.75	10.48	-
Net Cash (Debt)	345.19	158.29	28.04	82.61
Net Cash Growth	317.86%	464.45%	-66.05%	-
Net Cash Per Share	35.45	41.02	9.56	32.05
Filing Date Shares Outstanding	44.09	44.12	3.05	2.58
Total Common Shares Outstanding	44.09	4.72	3.05	2.58
Working Capital	264.15	140.57	31.17	75.58
Book Value Per Share	7.98	-34.66	-37.66	-27.13
Tangible Book Value	351.77	-163.71	-114.88	-69.92
Tangible Book Value Per Share	7.98	-34.66	-37.66	-27.13
Machinery	2.27	2.18	2.05	0.62
Construction In Progress	-	-	-	1.52
Leasehold Improvements	1.85	1.85	1.85	-

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q